Aquatic toxicity of the macrolide antibiotic clarithromycin and its metabolites

Chemosphere

Volumn 120, Issue , 2015, Pages 192-198

  Baumann, Michaela ^a   Weiss, Klaus ^a   Maletzki, Dirk ^b   Schüssler, Walter ^a   Schudoma, Dieter ^b   Kopf, Willi ^a   Kühnen, Ute ^b  

^a Bavarian Environment Agency   (Germany)

^b UMWELTBUNDESAMT   (Germany)

Author keywords

14 Hydroxy(R) clarithromycin; Clarithromycin; Environmental quality standards; N Desmethyl clarithromycin; Risk assessment; Toxicity testing

Indexed keywords

ANTIBIOTICS; AQUATIC ORGANISMS; BIOMOLECULES; ERBIUM COMPOUNDS; QUALITY CONTROL; RISK ASSESSMENT; SURFACE WATERS; TOXICITY; WATER;

CLARITHROMYCIN; CYANOBACTERIUM ANABAENA; DESMODESMUS SUBSPICATUS; ECOTOXICOLOGICAL STUDY; ENVIRONMENTAL QUALITY STANDARDS; ENVIRONMENTAL RISK ASSESSMENT; EXPOSURE CONCENTRATION; TOXICITY TESTING;

METABOLITES;

CLARITHROMYCIN; FRESH WATER; ANTIINFECTIVE AGENT; MACROLIDE; WATER POLLUTANT;

ANTIBIOTICS; AQUATIC ECOSYSTEM; BIOMONITORING; CONCENTRATION (COMPOSITION); ECOTOXICOLOGY; ENVIRONMENTAL RISK; FISH; GREEN ALGA; METABOLITE; SURFACE WATER; TOXICITY TEST; WATER QUALITY;

ANABAENA; AQUATIC ENVIRONMENT; AQUATIC SPECIES; ARTICLE; CYANOBACTERIUM; DAPHNIA MAGNA; GREEN ALGA; IMMOBILIZATION; LEMNA MINOR; TOXICITY TESTING; WATER CONTAMINATION; ZEBRA FISH; ANIMAL; DRUG EFFECTS; TOXICITY; WATER POLLUTANT;

ANIMALS; ANTI-BACTERIAL AGENTS; AQUATIC ORGANISMS; CLARITHROMYCIN; MACROLIDES; WATER POLLUTANTS, CHEMICAL;

EID: 84912118650     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2014.05.089     Document Type: Article

References (62)

1. Abegglen, C., 2010. Mikroverunreinigungen in Kläranlagen. GWA 7/2010.
2. Abegglen, C., Siegrist, H., 2012. Mikroverunreinigungen aus kommunalem Abwasser. Verfahren zur weitergehenden Elimination auf Kläranlagen. Bundesamt für Umwelt BAFU, Bern 2012.
3. Abegglen, C., Escher, B., Hollender, J., Koepke, S., Ort, C., Peter, A., Siegrist, H., von Gunten, U., Zimmermann, S., 2009. Ozonung von gereinigtem Abwasser. Schlussbericht Pilotversuch Regensdorf. EAWAG Bericht Dübendorf, 16. June 2009.
4. Alexy R., Kümpel T., Kümmerer K. Assessment of degradation of 18 antibiotics in the closed bottle test. Chemosphere 2004, 57:505-512.
5. Beier S., Cramer C., Köster S., Mauer C., Palmowski L., Schröder H.F., Pinnekamp J. Full scale membrane bioreactor treatment of hospital wastewater as forerunner for hot-spot wastewater treatment solutions in high density urban areas. Water Sci. Technol. 2011, 63:66-71.
6. BLAC-Bund/Länderausschuss für Chemikaliensicherheit, 2003. Arzneimittel in der Umwelt. Auswertung der Untersuchungsergebnisse. Bericht an die 61. Umweltministerkonferenz (UMK) am 19./20. November 2003 in Hamburg.
7. Calamari D., Zuccato E., Castiglioni S., Bagnati R., Fanelli R. Strategic survey of therapeutic drugs in the rivers Po and Lambro in Northern Italy. Environ. Sci. Technol. 2003, 37:1241-1248.
8. Dolar D., Gros M., Rodriguez-Mozaz S., Moreno J., Comas J., Rodriguez-Roda I., Barceló D. Removal of emerging contaminants from municipal wastewater with an integrated membrane system, MBR-RO. J. Hazard. Mater. 2012, 239-240:64-69.
9. Drug Bank., 2013. Open data drug & drug target data base, DB01211 (APRD00181). http://www.drugbank.ca/drugs/DB01211.
10. Ebert I., Hein A. Pharmaceuticals in the environment - a first compilation of german monitoring data. Umweltbundesamt, IV 2013, 2:2.
11. Ebert I., Bachmann J., Kühnen U., Küster A., Kussatz C., Maletzki D., Schlüter C. Toxicity of the fluoroquinolone antibiotics enrofloxacin and ciprofloxacin to photoautotrophic aquatic organisms. Environ. Toxicol. Chem. 2011, 30:2786-2792.
12. EMA, 2011. Questions and answers on Guideline on the environmental risk assessment of medicinal products. London, UK: European Medicines Agency. Rapport nr. EMA/CHMP/SWP/44609/2010.
13. Fatta-Kassinos D., Meric S., Nikolaou A. Pharmaceutical residues in environmental waters and wastewater: current state of knowledge and future research. Anal. Bioanal. Chem. 2011, 399:251-275.
14. Feitosa-Felizzola J., Chiron S. Occurrence and distribution of selected antibiotics in a small Mediterranean stream (Arc River, Southern France). J. Hydrol. 2009, 364:50-57.
15. Ferrero J.L., Bopp B.A., Marsh K.C., Quigley S.C., Johnson M.J., Anderson D.J., Lamm J.E., Tolman K.G., Sanders S.W., Cavanaugh J.H. Metabolism and disposition of clarithromycin in man. Drug Metabol. Dispos. 1990, 18:441-446.
16. Göbel A., Thomsen A., McArdell C.S., Joss A., Giger W. Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environ. Sci. Technol. 2005, 39:3981-3989.
17. Göbel A., McArdell C.S., Joss A., Siegrist H., Giger W. Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. Sci. Total Environ. 2007, 372:361-371.
18. González-Pleiter M., Gonzalo S., Rodea-Palomares I., Leganés F., Rosal R., Boltes K., Marco E., Fernández-Piñas F. Toxicity of five antibiotics and their mixtures towards photosynthetic aquatic organisms: implications for environmental risk assessment. Water Res. 2013, 47:2050-2064.
19. Goossen H. Outpatient antibiotic use in Europe and association with resistance; a crossnational database study. Lancet 2005, 365:579-587.
20. Götz C.W., Stamm C., Fenner K., Singer H., Schärer M., Hollender J. Targeting aquatic microcontaminants for monitoring: exposure categorization and application to the Swiss situation. Environ. Sci. Pollut. Res. 2010, 17:341-354.
21. Halling-Sørensen B. Algal toxicity of antibacterial agents used in intensive farming. Chemosphere 2000, 40:731-739.
22. Harada A., Komori K., Nakada N., Kitamura K. Biological effects of PPCPs on aquatic lives and evaluation of river waters affected by different wastewater treatment levels. Water Sci. Technol. 2008, 58:1514-1546.
23. Hardy D.J., Swanson R.N., Rode R.A., Marsh K., Shipkowitz N.L., Clement J.J. Enhancement of the in vitro and in vivo activities of clarithromycin against Heamophilus influencae by 14-hydroxy-clarithromycin, its major metabolite in humans. Antimicrob. Agents Chemother. 1990, 34:1407-1413.
24. IMS Health AG MIDAS Database 2013, Frankfurt/Main, Germany.
25. Isidori M., Lavorgna M., Nardelli A., Pascarella L., Parrella A. Toxic and genotoxic evaluation of six antibiotics on non-target organisms. Sci. Total Environ. 2005, 346:87-98.
26. Jelic A., Gros M., Ginebreda A., Cespedes-Sánchez R., Ventura F., Petrovic M., Barcelo D. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Res. 2011, 45:1165-1176.
27. Jorgensen J.H., Maher L.A., Howell A.W. Activity of clarithromycin and its principal human metabolite against Haemophilus influenzae. Antimicrob. Agents Chemother. 1991, 35:1524-1526.
28. Kase, R., Eggen, R.I.L., Junghans, M., Götz, C., Hollender, J., 2011. Assessment of micropollutants from municipal wastewater - combination of exposure and ecotoxicological effect data for Swizerland. In: Einschlag, F.S.G. (Ed.), Waste Water - Evaluation and Management, ISBN: 978-953-307-233-3, InTech. http://www.oekotoxzentrum.ch/dokumentation/publikationen/doc/bookchapter.
29. Kim S.-C., Carlson K. Temporal and spatial trends in the occurrence of human and veterinary antibiotics in aqueous and river sediment matrices. Environ. Sci. Technol. 2006, 41:50-57.
30. Kim J.-W., Ishibashi H., Yamauchi R., Ichikawa N., Takao Y., Hirano M., Koga M., Arizono K. Acute toxicity of pharmaceutical and personal care products on freshwater crustacean (Thamnocephalus platyurus) and fish (Oryzias latipes). J. Toxicol. Sci. 2009, 34:227-232.
31. Köhler C., Venditti S., Igos E., Klepiszewski K., Benetto E., Cornelissen A. Elimination of pharmaceutical residues in biologically pre-treated hospital wastewater using advanced UV irradiation technology: a comparative assessment. J. Hazard. Mater. 2012, 239-240:70-77.
32. Kovalova L., Siegrist H., Singer H., Wittmer A., McArdell C.S. Hospital wastewater treatment by membrane bioreactor: performance and efficiency for organic micropollutant elimination. Environ. Sci. Technol. 2012, 46:1536-1545.
33. Kümmerer K. Antibiotics in the aquatic environment - a review - Part I. Chemosphere 2009, 75:417-434.
34. Kümmerer K. Antibiotics in the aquatic environment - a review - Part II. Chemosphere 2009, 75:435-441.
35. Kümmerer K., Henninger A. Promoting resistance by the emission of antibiotics from hospitals and households into effluent. Clin. Microbiol. Infect. 2003, 9:1203-1214.
36. Kümmerer, K., Schuster, A., Längin, A., 2009. Identifizierung und Bewertung ausgewählter Arzneimittel und ihrer Metaboliten im Wasserkreislauf. Projektbericht FKZ 20661202.
37. Lange F., Cornelissen S., Kubac D., Sein M.M., von Sonntag J., Hannich C.B., Goloch A., Heipieper H.J., Möder M., von Sonntag C. Degradation of macrolide antibiotics by ozon: a mechanistic case study with clarithromycin. Chemosphere 2006, 65:17-23.
38. Le-Minh N., Khan S.J., Drewes J.E., Stuetz R.M. Fate of antibiotics during municipal water recycling treatment processes. Water Res. 2010, 44:4295-4323.
39. LfU, 2009. Arzneimittelwirkstoffe und ausgewählte Metaboliten - Untersuchungen in bayerischen Gewässern 2004-2008. Bayerisches Landesamt für Umwelt, Umwelt Spezial. http://www.lfu.bayern.de/wasser.
40. Lin A.Y.-C., Yu T.-H., Lateef S.K. Removal of pharmaceuticals in secondary wastewater treatment processes in Taiwan. J. Hazard. Mater. 2009, 167:1163-1169.
41. López-Serna R., Petrović M., Barceló D. Occurrence and distribution of multi-class pharmaceuticals and their active metabolites and transformation products in the Ebro River basin (NE Spain). Sci. Total Environ. 2012, 440:280-289.
42. McArdell C.S., Molnar E., Suter M.J.F., Giger W. Occurrence and fate of macrolide antibiotics in wastewater treatment plants and in the Glatt valley watershed. Switzerland. Environ. Sci. Technol. 2003, 37:5479-5486.
43. Miao X.-S., Bishay F., Chen M., Metcalfe C.D. Occurrence of antimicrobials in the final effluents of wastewater treatment plants in Canada. Environ. Sci. Technol. 2004, 38:3533-3541.
44. Michael I., Rizzo L., McArdell C.S., Manaia C.M., Merlin C., Schwartz T., Dagot C., Fatta-Kassinos D. Urban wastewater treatment plants as hotspots for the release of antibiotics in the environment: a review. Water Res. 2013, 47:957-995.
45. Nakagawa Y., Itai S., Yoshida T., Nagai T. Physicochemical properties and stability in the acidic solution of a new macrolide antibiotic, clarithromycin, in comparison with erythromycin. Chem. Pharm. Bull. 1992, 40:725-728.
46. OECD, 2006. Current approaches in the statistical analysis of ecotoxicity data: A guidance to application. Organisation for Economic Co-operation and Development. Peport nr EVV/JM/MONO(2006) 18 Number 54, n 1-147.
47. Robinson A.A., Belden J.B., Lydy M.J. Toxicity of fluoroquinolone antibiotics to aquatic organisms. Environ. Toxicol. Chem. 2005, 24:423-430.
48. Rodrigues A.D., Roberts E.M., Mulford D.J., Yao Y., Ouellet D. Oxidative metabolism of clarithromycin in the presence of human liver microsomes: major role for the cytochrome P4503A (CYP3A) subfamily. Drug Metab. Dispos. 1997, 25:623-630.
49. Sahar E., Messalem R., Cikurel H., Aharoni A., Brenner A., Godehardt M., Jekel M., Ernst M. Fate of antibiotics in activated sludge followed by ultrafiltration (CAS-UF) and in a membrane bioreactor (MBR). Water Res. 2011, 45:4827-4836.
50. Senta I., Matošić M., Jakopović H.K., Terzic S., Ćurko J., Mijatović I., Ahel M. Removal of antimicrobials using advanced wastewater treatment. J. Hazard. Mater. 2011, 192:319-328.
51. Senta I., Terzic S., Ahel M. Occurrence and fate of dissolved and particulate antimicrobials in municipal wastewater treatment. Water Res. 2013, 47:705-714.
52. Spongberg A.L., Witter J.D. Pharmaceutical compounds in the wastewater process stream in Northwest Ohio. Sci. Total Environ. 2008, 397:148-157.
53. TGD-EQS, Technical guidance for deriving environmental quality standards. European communities technical report 2011-055.
54. UBA Zusammenstellung des Umweltbundesamtes nach Angaben der Länderarbeitsgemeinschaft Wasser (LAWA) 2010, Umweltbundesamt, Berlin.
55. UBA, 2011. Zusammenstellung von Monitoringdaten zu Umweltkonzentrationen von Arzneimitteln. Umweltbundesamt Texte 66/2011.
56. Verlicchi P., Al Aukidy M., Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment - a review. Sci. Total Environ. 2012, 429:123-155.
57. Verlicchi P., Al Aukidy M., Galletti A., Petrovic M., Barceló D. Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment. Sci. Total Environ. 2012, 430:109-118.
58. Vione D., Feitosa-Felizzola J., Minero C., Chiron S. Phototransformation of selected human-used macrolides in surface water: kinetics, model predictions and degradation pathways. Water Res. 2009, 43:1959-1967.
59. Weiß, K., Baumann, M., Schüßler, W., Maletzki, D., Kussatz, C., 2012. Toxicity of the antibiotic clarithromycin to aquatic organisms, a comparison of species sensitivity. In: SETAC Europe 22th Annual Meeting. Bavarian Environment Agency (LfU) and Federal Environment Agency (UBA), Berlin.
60. Yamashita N., Yasojima M., Nakada N., Miyajima K., Komori K., Suzuki Y., Tanaka H. Effects of antibacterial agents, levofloxacin and clarithromycin, on aquatic organisms. Water Sci. Technol. 2006, 53:65-72.
61. Yang L.-H., Ying G.-G., Su H.-C., Stauber J.L., Adams M.S., Binet M.T. Growth-inhibiting effects of 12 antibacterial agents and their mixtures on the freshwater microalga Pseudokirchneriella subcapitata. Environ. Toxicol. Chem. 2008, 27:1201-1208.
62. Zuccato E., Castiglioni S., Bagnati R., Melis M., Fanelli R. Source, occurrence and fate of antibiotics in the Italian aquatic environment. J. Hazard. Mater. 2010, 179:1042-1048.